Paraneoplastic autoantibody evaluation, CSF-14306

Test info

  
Paraneoplastic autoantibody evaluation, CSF
  
14306
  
LAB14306
  
PAC1
  
Anti-Hu
Antineuronal
Cerebellar antibodies
Dorsal root ganglion antibody
  
  • Paraneoplastic Interpretation, CSF
  • Anti-Neuronal Nuclear Ab, Type 1
  • Anti-Neuronal Nuclear Ab, Type 2
  • Anti-Neuronal Nuclear Ab, Type 3
  • Anti-Glial Nuclear Ab, Type 1
  • Purkinje Cell Cytoplasmic Ab Type 1
  • Purkinje Cell Cytoplasmic Ab Type 2
  • Purkinje Cell Cytoplasmc Ab Type Tr
  • Amphiphysin Ab, CSF
  • CRMP-5-IgG, CSF
  
  • An aid in the diagnosis of paraneoplastic neurological autoimmune disorders related to carcinoma of lung, breast, ovary, thymoma, or Hodgkin's lymphoma
  • In patients with a history of tobacco use or other lung cancer risk, or if thymoma is suspected, Paraneoplastic autoantibody evaluation, serum is also recommended.

Specimen

  
Cerebrospinal fluid (CSF)
  
4.0 mL
  
2.0 mL
  

Do not spin; submit entire specimen

  

Refrigerated (preferred) - 28 days

Ambient - 72 hours

Frozen - 28 days

Performance

  
Mayo Clinic Laboratories (PAC1): R-NX
  
Daily
  
3 - 4 days if Negative;5 - 8 days if Positive
  

Immunofluorescence Assay (IFA), Radioimmunoassay, Cell-Binding Assay (CBA) and Western Blot

Clinical and Interpretive info

  

Negative at < 1:2

Billing

  
86255 x 9

Additional CPT codes (if appropriate):
83519
84182 x 7
86255 x 9
86256 x 5
86341

Tracking

  
06/05/2013
  
05/19/2020